Literature DB >> 15558922

Leukemoid reactions complicating colitis due to Clostridium difficile.

Mark A Marinella1, Steven D Burdette, Roger Bedimo, Ronald J Markert.   

Abstract

BACKGROUND: We sought to describe the characteristics of patients who had Clostridium difficile colitis complicated by leukemoid reactions (total leukocyte count greater than 35 x 10(9)/L) and to determine whether this complication is associated with higher morbidity or mortality than C difficile colitis without leukemoid reactions.
METHODS: We performed a retrospective case series analysis of patients with a positive fecal assay for C difficile toxin and a peak leukocyte count greater than 35 x 10(9)/L during 1998 and 1999. Twenty cases that met these criteria were compared with 65 randomly selected control patients (patients with a positive C difficile toxin and a peak leukocyte count less than 35 x 10(9)/L).
RESULTS: The mean peak leukocyte count was 52 +/- 18.2 x 10(9)/L (+/- SD) in the case group and 14.9 +/- 6.5 x 10(9)/L in the control group. Patients with a leukemoid reaction had a lower temperature, a lower serum albumin level, and a higher hematocrit value. Multivariable logistic regression showed respiratory tract infection and lower temperature to be independent predictors of a leukemoid reaction. There were 10 deaths (50%) in the leukemoid reaction group and 5 deaths (7.7%) in the control group. All seven patients with a peak leukocyte count greater than 50 x 10(9)/L died, compared with eight deaths (10.3%) among the remaining 78 patients whose peak leukocyte count was less than 50 X 10(9)/L.
CONCLUSION: Patients with C difficile colitis and a leukocyte count greater than 35 x 10(9)/L have a poor prognosis with a much higher mortality rate than patients who have C difficile colitis without a leukemoid reaction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15558922     DOI: 10.1097/01.SMJ.0000054537.20978.D4

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  6 in total

1.  Clostridium difficile: The evolving story.

Authors:  Bl Johnston; Jm Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-11       Impact factor: 2.471

2.  When leucocytosis is not leukaemia.

Authors:  Filip Ionescu; Nwabundo Anusim; Vonda Douglas-Nikitin; Michael Stender
Journal:  BMJ Case Rep       Date:  2019-05-24

3.  Moderate to severe leukocytosis with vasopressor use is associated with increased mortality in trauma patients.

Authors:  Bima J Hasjim; Areg Grigorian; Stephen Stopenski; Lourdes Swentek; Beatrice Sun; Joshua K Livingston; Barbara Williams; Frank Nastanski; Jeffry Nahmias
Journal:  J Intensive Care Soc       Date:  2020-12-09

4.  Leukemoid reaction in the pediatric population: etiologies, outcome, and implications.

Authors:  Assaf Hoofien; Havatzelet Yarden-Bilavski; Shai Ashkenazi; Gabriel Chodick; Gilat Livni
Journal:  Eur J Pediatr       Date:  2018-04-25       Impact factor: 3.183

5.  Bullous mycosis fungoides associated with an extensive ulcer and a severe leukemoid reaction.

Authors:  Shuei Sato; Osamu Okamoto; Michifumi Kawamoto; Masaki Oishi; Naomi Yada; Kazuhiro Kohno; Shigeo Yokoyama; Sakuhei Fujiwara
Journal:  Dermatol Reports       Date:  2011-12-02

6.  Experimental identification and computational characterization of a novel extracellular metalloproteinase produced by Clostridium sordellii.

Authors:  Michael J Aldape; Aoxiang Tao; Dustin D Heeney; Eric R McIndoo; John M French; Dong Xu
Journal:  RSC Adv       Date:  2017-03-02       Impact factor: 3.361

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.